Full text not available from this repository.

Abstract

Asthma is a common, heterogeneous and serious disease with high prevalence globally. Poorly controlled, steroid-resistant asthma is particularly important as there are no effective therapies and it exerts substantial healthcare and societal burden. The role of microbiomes, particularly in chronic diseases has generated considerable interest in recent times. Existing evidence clearly demonstrates an association between asthma initiation and the microbiome, both respiratory and gastro-intestinal, although its' roles are poorly understood when assessing the asthma progression or heterogeneity (i.e. phenotypes/endotypes) across different geographical locations. Moreover, modulating microbiomes could be preventive and/or therapeutic in patients with asthma warrants urgent attention. Here, we review recent advances in assessing the role of microbiomes in asthma and present the challenges associated with the potential therapeutic utility of modifying microbiomes in management.

Item Type:	Article
Authors/Creators:	Shukla, SD and Shastri, MD and Chong, WC and Dua, K and Budden, KF and Mahmood, MQ and Hansbro, NG and Keely, S and Eri, R and Patel, RP and Peterson, GM and Hansbro, PM
Keywords:	asthma, microbiome, management, pharmacology, inflammation
Journal or Publication Title:	Current Opinion in Pharmacology
Publisher:	Elsevier Sci Ltd
ISSN:	1471-4892
DOI / ID Number:	https://doi.org/10.1016/j.coph.2019.06.003
Copyright Information:	Copyright 2019 Elsevier Ltd. All rights reserved.
Related URLs:	UTAS Profile: Shastri, MD Google Scholar: Eri, R UTAS Profile: Eri, R UTAS Profile: Patel, RP UTAS Profile: Peterson, GM
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page